
Emerging SME Services · BSE
Astonea Labs Ltd., established in 2017, is engaged in the contract manufacturing of pharmaceutical and cosmetic products for both Indian and international companies. The company produces a wide range of medicines, including antibiotics and treatments for colds, infections, diabetes, heart conditions, and gynecological issues. It also manufactures skincare, haircare, and dental care products in the form of gels, creams, and serums. In addition to manufacturing, Astonea Labs provides packaging and raw materials to other pharmaceutical and cosmetic companies, adhering to industry standards. The company markets its own brands—Glow Up, a dermo-cosmetic line, and Regero, a pharmaceutical range—and is preparing to launch a new brand named Avicel. It also exports products to countries like Iraq and Yemen. As of August 16, 2024, the company had 217 employees on its payroll.
Price Band
₹128 – ₹135
Issue Size
₹37.67 Cr
Lot Size
1000 shares
GMP
Est. Listing
₹135
at current GMP
Subscribed
2.55x
overall
Open
27 May 2025
Close
29 May 2025
Allotment
30 May 2025
Refund
31 May 2025
Demat Credit
1 Jun 2025
Listing
3 Jun 2025
Last updated: 19 Oct 2026
Current Premium
Issue Price (Upper)
₹135
Band: ₹128 – ₹135
Estimated Listing Price
₹135
Upper price + GMP
Lot Size
1000 shares
Min investment ₹1,35,000
Estimated Profit / Lot
₹0
1000 × ₹0
Grey Market Premium trend
—
▲ 0 today
Updated less than a minute ago
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹135 |
| 30 Oct 2026 | — | 0.0% | ₹135 |
| 29 Oct 2026 | — | 0.0% | ₹135 |
GMP is unofficial market data. Not a guarantee of listing performance.
Astonea Labs Limited is bringing an initial public offering (IPO) in the Emerging SME Services sector with an aggregate issue size of ₹37.67 Crores. The shares are offered at a price band of ₹128 to ₹135 per equity share on BSE. Currently, grey market participants and retail investors are watching the bidding trend, premium movement, and anchor book demand with keen interest.
Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 1000 shares (approx. ₹1,35,000 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.
Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-06-01, while un-allotted funds or UPI block mandates will be released on 2025-05-31.
The latest grey market premium for Astonea Labs Limited IPO is ₹0, which indicates an expected listing price of ₹135.
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.